TrialLancet (London, England)2019

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Hiddo J L Heerspink et al.PubMed ↗Publisher ↗

No numbers read from the abstract.